Drg Stimulator denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for drg stimulator are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Requires Prior Authorization for a Dorsal Root Ganglion Stimulator

BCBS requires prior authorization for implantable neuromodulation devices — including dorsal root ganglion (DRG) stimulators — because they are high-cost procedures with specific clinical criteria that must be met before approval. A "prior auth required" denial occurs when the device was implanted or requested without a completed and approved PA, or when a submitted PA was denied because the documentation did not satisfy BCBS's review criteria. Understanding which situation applies determines the correct appeal strategy.

## Why This Is Appealable

If the PA was denied, the denial is a coverage determination with full appeal rights — BCBS must tell you specifically which criteria were not met, and you are entitled to submit additional documentation addressing those gaps. If the PA was not obtained before the procedure, there may still be a retrospective review pathway or an exception process, though the burden is higher. Either way, the appeal is not futile: PA denials for DRG stimulators are regularly overturned when comprehensive clinical documentation is provided.

## Federal Appeal Framework

• Internal appeal: File within 180 days of the denial. For prospective (pre-service) PA denials, BCBS must respond within 15 days (standard) or 72 hours (urgent/expedited). For retrospective reviews, the timeline differs — check your plan documents.
• External review (ACA §2719): If internal appeal fails, request independent external review within 4 months. The IRO reviews the clinical record without deference to BCBS's initial determination.
• ERISA §503 (self-funded plans): Full-and-fair review rights apply; procedural failures by BCBS (e.g., failure to specify which criteria were unmet) are reviewable.
• Expedited review: Request explicitly if the standard timeline would harm your health.

## Documentation to Gather

1. The PA denial letter — the specific language citing which criteria were not satisfied; this is your roadmap for the appeal. 2. BCBS's current PA criteria for DRG stimulation — obtain the live medical policy from BCBS's medical policy library and address every criterion individually. 3. Diagnosis and severity documentation — specialist evaluation, imaging, objective pain assessments, and functional impact records. 4. Comprehensive prior treatment history — a dated list of all conservative and interventional treatments tried before the DRG stimulator was recommended, with documented outcomes. 5. Stimulator trial results — if a trial was performed, objective outcome data (pain scores, functional measures) from the trial period. 6. Implanting physician medical-necessity letter — a detailed clinical letter addressing each BCBS PA criterion with specific facts from the patient's chart.

## Criteria-Mapping Structure

| BCBS PA Criterion | Patient-Specific Documentation | |---|---| | Qualifying diagnosis | [Specialist evaluation, diagnostic records] | | Prior conservative treatment completed | [Dated treatment history] | | Objective functional impairment | [Assessment scores, chart notes] | | Successful stimulator trial | [Trial outcome data] | | Implanting physician attestation | [Medical-necessity letter] |